- Home
- ESGL vs FBRX Comparison
ESGL vs FBRX Comparison
Compare ESGL & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESGL
- FBRX
- Stock Information
- Founded
- ESGL 1999
- FBRX N/A
- Country
- ESGL Singapore
- FBRX United States
- Employees
- ESGL N/A
- FBRX N/A
- Industry
- ESGL
- FBRX Biotechnology: Pharmaceutical Preparations
- Sector
- ESGL
- FBRX Health Care
- Exchange
- ESGL Nasdaq
- FBRX Nasdaq
- Market Cap
- ESGL 154.3M
- FBRX 154.5M
- IPO Year
- ESGL N/A
- FBRX N/A
- Fundamental
- Price
- ESGL $3.69
- FBRX $10.56
- Analyst Decision
- ESGL
- FBRX Strong Buy
- Analyst Count
- ESGL 0
- FBRX 3
- Target Price
- ESGL N/A
- FBRX $68.00
- AVG Volume (30 Days)
- ESGL 22.8K
- FBRX 69.5K
- Earning Date
- ESGL 09-23-2025
- FBRX 08-14-2025
- Dividend Yield
- ESGL N/A
- FBRX N/A
- EPS Growth
- ESGL N/A
- FBRX N/A
- EPS
- ESGL N/A
- FBRX N/A
- Revenue
- ESGL $6,099,784.00
- FBRX N/A
- Revenue This Year
- ESGL N/A
- FBRX N/A
- Revenue Next Year
- ESGL N/A
- FBRX N/A
- P/E Ratio
- ESGL N/A
- FBRX N/A
- Revenue Growth
- ESGL N/A
- FBRX N/A
- 52 Week Low
- ESGL $0.90
- FBRX $4.11
- 52 Week High
- ESGL $3.87
- FBRX $28.68
- Technical
- Relative Strength Index (RSI)
- ESGL 73.44
- FBRX 43.42
- Support Level
- ESGL $3.33
- FBRX $10.65
- Resistance Level
- ESGL $2.70
- FBRX $11.57
- Average True Range (ATR)
- ESGL 0.24
- FBRX 0.85
- MACD
- ESGL 0.10
- FBRX -0.09
- Stochastic Oscillator
- ESGL 91.63
- FBRX 18.83
About ESGL ESGL Holdings Limited
ESGL Holdings Ltd is a waste management, treatment, and recycling company involved in the collection and recycling of hazardous and non-hazardous industrial waste from customers such as pharmaceutical, semiconductor, petrochemical, and electroplating companies.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).